Gecina published its 9m figures. GRI stood at €419.2m, down -1.3% yoy (-0.7% lfl). EBITDA at €345.3m is down 2.6% yoy and net income at €273m, up 2.9% yoy. Cost of debt now stands at 2.2% (1.7% on drawn debt, and management has secured €194m of disposals in Residential assets. The group has revised its EPS guidance for FY16, now targeting 7% growth excluding Gecimed, from 5% previously.
21 Oct 2016
9M figures: NRI growth supported by stronger financial structure
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
9M figures: NRI growth supported by stronger financial structure
Gecina SA (GFC:WBO) | 0 0 2.8% | Mkt Cap: 11,480m
- Published:
21 Oct 2016 -
Author:
Alda Kule Dale -
Pages:
2
Gecina published its 9m figures. GRI stood at €419.2m, down -1.3% yoy (-0.7% lfl). EBITDA at €345.3m is down 2.6% yoy and net income at €273m, up 2.9% yoy. Cost of debt now stands at 2.2% (1.7% on drawn debt, and management has secured €194m of disposals in Residential assets. The group has revised its EPS guidance for FY16, now targeting 7% growth excluding Gecimed, from 5% previously.